Insight Molecular Diagnostics Inc. Disposal Group, Including Discontinued Operation, Assets, Noncurrent
Insight Molecular Diagnostics Inc. (IMDX) had Disposal Group, Including Discontinued Operation, Assets, Noncurrent of $29.68 million as of 2021-12-31, per its 10-K filed 2023-04-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent · last filed 2023-04-12
- 2021-12-31: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $29.68M.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Noncurrent |
|---|---|
| 2021-12-31 | $29.68M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |